Previous 10 | Next 10 |
Insignia Systems press release ( NASDAQ: ISIG ): Q2 GAAP EPS of -$0.61. Revenue of $3.3M (-45.9% Y/Y). For further details see: Insignia Systems GAAP EPS of -$0.61, revenue of $3.3M
MINNEAPOLIS, MN / ACCESSWIRE / August 9, 2022 / Insignia Systems, Inc. (Nasdaq:ISIG) ("Insignia") today reported financial results for the second quarter ended June 30, 2022 ("Q2"). Overview Q2 2022 net sales decreased 46.6% to $3.3 million from $6.1 million in Q2 2021. Q2 2022 opera...
Insignia Systems (NASDAQ:ISIG) shows a 5.1% stake of David E. Lazar, an experienced private investor specializing in reverse merger and other event-driven opportunities. He comments, “I invested in ISIG due to the Company’s stated intention to explore strategic options to m...
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, an experienced private investor specializing in reverse merger and other event-driven opportunities, today filed a Schedule 13D announcing his acquisition of approximately 5.1% of the common stock outstanding of Insignia Systems, In...
Gainers: Vivid Seats (SEATW) +34%. MOGU (MOGU) +29%. Modine Manufacturing Company (MOD) +28%. Insignia Systems (ISIG) +24%. Baozun (BZUN) +22%. Losers: China Liberal Education Holdings (CLEU) -26%. Reservoir Media (RSVRW) -17%. Vinco Ventures (BBIG) -13%. Willamett...
Insignia Systems press release (NASDAQ:ISIG): Q1 GAAP EPS of $0.03. Revenue of $6.1M (+12.5% Y/Y). For further details see: Insignia Systems GAAP EPS of $0.03, revenue of $6.1M
MINNEAPOLIS, MN / ACCESSWIRE / May 10, 2022 / Insignia Systems, Inc. (Nasdaq:ISIG) ("Insignia") today reported financial results for the first quarter ended March 31, 2022 ("Q1"). Overview Q1 2022 net sales increased 14.1% to $6.1 million from $5.4 million in Q1 2021. Q1 2022 opera...
Gainers: Protalix BioTherapeutics (PLX) +74%. Aterian (ATER) +62%. Dingdong Limited (DDL) +40%. Jumia Technologies (JMIA) +30%. Twitter (TWTR) +27%. Takung Art (TKAT) +24%. Gracell Biotechnologies (GRCL) +22%. Cognition Therapeutics (CGTX) +21%. Poema Global Holdings (PPGH) +20%. Biophytis (B...
Gainers: Aterian (ATER) +57%. Takung Art Co (TKAT) +29%. Jumia Technologies (JMIA) +27%. Twitter (TWTR) +27%. Dingdong (Cayman) Limited (DDL) +24%. Losers: Insignia Systems (ISIG) -17%. Yunhong CTI (CTIB) -17%. Direct Digital Holdings (DRCT) -12%. Int...
Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....
News, Short Squeeze, Breakout and More Instantly...
Insignia Systems Inc. Company Name:
ISIG Stock Symbol:
NASDAQ Market:
Insignia Systems Inc. Website:
MINNEAPOLIS, MN / ACCESSWIRE / May 9, 2023 / Insignia Systems, Inc. (Nasdaq:ISIG) ("Insignia") today reported financial results for the first quarter ended March 31, 2023 ("Q1"). Overview Q1 2023 net sales increased 108.7% to $12.8 million from $6.1 million in Q1 2022. Q1 2023 operatin...
MINNEAPOLIS, MN / ACCESSWIRE / April 7, 2023 / Insignia Systems, Inc. (Nasdaq:ISIG) ("Insignia") today announced the hire of Randy Uglem as its Senior Vice President of Lending. Mr. Uglem will oversee the Company's newly-created Non-bank Lending Platform. Mr. Uglem has over twenty years of sig...
MINNEAPOLIS, MN / ACCESSWIRE / March 6, 2023 / Insignia Systems, Inc. (Nasdaq:ISIG) ("Insignia") today reported financial results for the fourth quarter ("Q4") and the full year ended December 31, 2022. Overview Q4 2022 net sales were $4.5 million, compared to $4.5 million in Q4 2021. ...